Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome
Open Access
- 1 December 2004
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 63 (12) , 1649-1654
Abstract
Objective: To study the long term effectiveness of intravenous immunoglobulin and plasmapheresis associated with prednisone and cyclophosphamide in Churg-Strauss syndrome. Subjects and methods: We studied 18 subjects with new onset Churg-Strauss syndrome. All received the “standard” treatment based on prednisone (1 mg/kg/day for 1 month and then slowly tapered) and cyclophosphamide (2 mg/kg/day for 6 months in severe cases). In nine patients, synchronised cycles with plasmapheresis and intravenous immunoglobulin (2 g/kg) were repeated monthly for 6 months and every other month for a further three cycles. Clinical (disease activity monitored by Birmingham vasculitis activity score (BVAS) and damage index (modified Rankin score)) and functional (C reactive protein, blood eosinophil count, and electromyogram-electoneurogram) parameters were collected during treatment and the 3 year follow up period. Results: After 12 months, all patients in the treatment group and four (44%) in the control group were in remission. At the end of the 3 year follow up period, we documented significant differences in BVAS (pConclusion: Complete clinical and functional recovery with a long term stable remission and a low incidence of side effects can be achieved by intravenous immunoglobulin associated with plasmapheresis in patients with Churg-Strauss syndrome.Keywords
This publication has 31 references indexed in Scilit:
- Recent Advances in the Diagnosis of Churg-Strauss SyndromeLaboratory Investigation, 2001
- Clinicopathological features of Churg–Strauss syndrome-associated neuropathyBrain, 1999
- Treatment‐free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamideArthritis & Rheumatism, 1994
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- ANCA Anti-Idiotype Antibodies and the Treatment of Systemic Vasculitis with Intravenous ImmunoglobulinJournal of Autoimmunity, 1993
- Treatment of Churg-Strauss syndrome with high-dose intravenous immunoglobulinJournal of Allergy and Clinical Immunology, 1991
- Treatment of systemic vasculitis with pooled intravenous immunoglobulinThe Lancet, 1991
- The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)Arthritis & Rheumatism, 1990
- Interobserver agreement for the assessment of handicap in stroke patients.Stroke, 1988
- The clinical spectrum of necrotizing angiopathy of the peripheral nervous systemAnnals of Neurology, 1985